Transcode Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Transcode Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2024.
  • Transcode Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 160 %, a 16.4% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 160 +22.6 +16.4% Sep 30, 2024
Q2 2024 163 -1.96 -1.19% Jun 30, 2024
Q1 2024 166 -77.3 -31.8% Mar 31, 2024
Q4 2023 128 -313 -71% Dec 31, 2023
Q3 2023 137 -539 -79.7% Sep 30, 2023
Q2 2023 165 -803 -83% Jun 30, 2023
Q1 2023 243 -583 -70.6% Mar 31, 2023
Q4 2022 440 Dec 31, 2022
Q3 2022 677 Sep 30, 2022
Q2 2022 968 Jun 30, 2022
Q1 2022 826 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.